Leveraging gold-standard PCR technology, the cobas liat system claims to deliver outcomes in under 20 minutes.
A new experimental vaccine developed by researchers at MIT and Caltech could offer protection against emerging variants of SARS-CoV-2, as well as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback